60 years old or younger
Showing 1 - 25 of >10,000
Esophagogastric Histopathology Potentially Guided Patients
Not yet recruiting
- Colorectal Neoplasms
- (no location specified)
Apr 26, 2023
Robot-Assisted Pyeloplasty in Young Children
Completed
- Ureterohydronephrosis
- +2 more
- Robot-Assisted Pyeloplasty
-
Vandœuvre-lès-Nancy, Grand-Est, FranceULorraine
May 14, 2023
COVID-19 Trial in Nanjing (One dose group, Two doses group, Aged 18-59 years)
Not yet recruiting
- COVID-19
- One dose group
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Dec 25, 2022
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)
Not yet recruiting
- Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
- (no location specified)
Feb 27, 2023
Raw EEG During Sevoflurane Anesthesia in Children Younger Than 2
Recruiting
- Anesthesia, General
- +2 more
- BIS
- PSi
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 13, 2022
Covid19 Trial in Xinxiang (3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated, 3-doses schedule 2 of COVID-19
Recruiting
- Covid19
- 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated
- +3 more
-
Xinxiang, Henan, ChinaYanjin County Center for Disease Control and Prevention
Jun 15, 2022
Vaccination Trial in Shanghai (23-valent pneumococcal polysaccharide vaccine)
Completed
- Vaccination
- 23-valent pneumococcal polysaccharide vaccine
-
Shanghai, Shanghai, ChinaShanghai municipal center for disease control and prevention
Feb 15, 2022
Lymphoma Trial in Houston (Rituximab, Cyclophosphamide, Doxorubicin)
Completed
- Lymphoma
- Rituximab
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 18, 2020
Rabies, Antibody Trial in Changchun (5 doses program)
Completed
- Rabies
- Antibody
- 5 doses program
-
Changchun, Jilin, ChinaChangchun Zhuoyi Biological Co., Ltd
Sep 18, 2022
COVID-19 Trial in Thái Bình (COVIVAC vaccine)
Completed
- COVID-19
- COVIVAC vaccine
-
Thái Bình, Thai Binh, VietnamDistrict Health Center of Vu Thu District
Jul 12, 2023
Respiratory Syncytial Virus Prevention Trial in United States (Ad26.RSV.preF-based vaccine)
Completed
- Respiratory Syncytial Virus Prevention
- Ad26.RSV.preF-based vaccine
-
San Diego, California
- +8 more
Oct 25, 2022
Influenza Trial in Saint Petersburg (Flu-M [Inactivated split influenza vaccine], Inactivated Split Influenza Vaccine)
Completed
- Influenza
- Flu-M [Inactivated split influenza vaccine]
- Inactivated Split Influenza Vaccine
-
Saint Petersburg, Russian Federation
- +1 more
Dec 16, 2021
Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))
Recruiting
- Acute Myeloid Leukemia
- A arm (DA-90)
- +3 more
-
New York, New York
- +9 more
Sep 30, 2021
Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- Vincristine Sulfate Liposomes Injection (VSLI)
- Vincristine Sulfate Injection (VSI)
-
La Jolla, California
- +14 more
Sep 6, 2021
Prevention of COVID19 Trial (mRNA-1273)
Not yet recruiting
- Prevention of COVID19
- mRNA-1273
- (no location specified)
Feb 6, 2021
Reverse Shoulder Replacement: Age 60 or Younger Outcomes
Completed
- Shoulder Arthritis
- shoulder x-ray
-
Saint Louis, MissouriWashington University School of Medicine
Jul 15, 2019
Malaria, Dengue, Influenza -Like Illness Trial in Senegal (Patient clinical management based on the CDSA strategy)
Recruiting
- Malaria
- +5 more
- Patient clinical management based on the CDSA strategy
-
Fatick, Senegal
- +3 more
Oct 26, 2021
Cryptogenic Ischemic Stroke, Patent Foramen Ovale Trial in France (Transcatheter PFO closure, Oral Anticoagulant, Direct-Acting,
Not yet recruiting
- Cryptogenic Ischemic Stroke
- Patent Foramen Ovale
- Transcatheter PFO closure
- +2 more
-
Amiens, France
- +30 more
May 20, 2022
Influenza Trial in Phu Ly, Thai Binh (IVACFLU-S)
Active, not recruiting
- Influenza
- IVACFLU-S
-
Phu Ly, Ha Nam, Vietnam
- +1 more
Jan 1, 2021
Coronavirus Trial in Xiangtan (Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group,
Unknown status
- Coronavirus
- Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group
- +2 more
-
Xiangtan, Changsha, ChinaHunan Provincial Center for Disease Control and Prevention
Jan 26, 2021
COVID-19 Trial in Wuhan (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector))
Completed
- COVID-19
- Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
-
Wuhan, Hubei, ChinaHubei Provincial Center for Disease Control and Prevention
Aug 2, 2021
Early Stage Alzheimer's Disease Through Speech Phenotyping -
Recruiting
- Alzheimer Disease
- +5 more
-
Santa Ana, CaliforniaSyrentis Clinical Research
Apr 6, 2022
Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening Trial (Changes in CRC screening awareness and
Not yet recruiting
- Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
- Changes in CRC screening awareness and intentions
- (no location specified)
Jun 30, 2023
Coronavirus Infections, Healthy Trial in Ribeirão Preto (NDV-HXP-S 1µg, NDV-HXP-S 3µg, NDV-HXP-S 10µg)
Recruiting
- Coronavirus Infections
- Healthy
- NDV-HXP-S 1μg (Stage A)
- +31 more
-
Ribeirão Preto, São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Aug 4, 2021
Leukemia, Myeloid, Acute, De Novo, Age More 60yr Trial in Spain (Azacitidine, Venetoclax, Quizartinib)
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- Azacitidine
- +3 more
-
Alcalá De Henares, Spain
- +14 more
May 17, 2021